Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: December 2021

FingerMotion Inc. (FNGR) Reports on November 22 Annual Meeting Results

Posted on December 3, 2021 by MissionIR

FingerMotion released results from the annual meeting held on November 22, 2021 It announced the re-appointment of executive officers and its Board of Directors It also reported on the appointment of an independent accounting firm FingerMotion (OTCQX: FNGR) held its … Continue reading →

Posted in FingerMotion Inc. FNGR | Leave a comment

Flora Growth Corp. (NASDAQ: FLGC) Enters Cannabis Beverages Market, Extends Portfolio of Luxury Products with Tonino Lamborghini Licensing Agreement

Posted on December 3, 2021 by MissionIR

Flora Growth recently entered into a licensing agreement to produce and distribute Tonino Lamborghini-branded cannabis beverages across North America and Colombia, with an initial focus on the U.S. market The company will produce the product line using molecular tagging and … Continue reading →

Posted in Small Cap News | Leave a comment

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF), The Digital Face of the Plant-Based Community

Posted on December 3, 2021 by MissionIR

PlantX seeks to redefine the plant-based community through e-commerce, content sharing, and community-building efforts With over 5,000 plant-based products, the company also promises to be the one-stop-shop for everything plant-based It is leveraging the internet and technology to bring its … Continue reading →

Posted in PlantX Life Inc. PLTXF | Leave a comment

MissionIRNewsBreaks – Excellon Resources Inc.’s (NYSE American: EXN) (TSX: EXN) (FSE: E4X2) Platosa Marks 4th Quarter of >21,000 Tons Mined and Milled

Posted on December 2, 2021 by MissionIR

Excellon Resources (NYSE American: EXN) (TSX: EXN) (FSE: E4X2) is a diversified metals producer with a precious metals growth pipeline that includes Mexico’s Platosa Mine, Kilgore, a high-quality gold development project in Idaho, as well as and an option on … Continue reading →

Posted in Excellon Resources Inc. EXN | Leave a comment

MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Embarking on Potentially Pivotal Study to Evaluate DehydraTECH-CBD

Posted on December 2, 2021 by MissionIR

Lexaria Bioscience Corp. (NASDAQ: LEXX) has embarked on its most ambitious study yet, the HYPER-H21-4. The study is among several geared towards evaluating DehydraTECH(TM)-processed CBD for the potential treatment of hypertension and heart disease. The learnings from two studies, HYPER-H21-1 … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Switzerland Ethics Committee Approval of Pivotal Berubicin Study

Posted on December 2, 2021 by MissionIR

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, has received approval from the Switzerland Ethics Committee (swissethics) — the first approval of … Continue reading →

Posted in CNS Pharmaceuticals Inc. CNSP, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Receives Initial Orders from Mexico, Spain

Posted on December 2, 2021 by MissionIR

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, is expanding internationally. The company’s Flora Beauty division received its first-ever orders for its Mind Naturals and Awe CBD skincare brands for the Spanish … Continue reading →

Posted in Flora Growth Corp. FLGC | Leave a comment

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Touts Highlights of ‘Transformative’ Second-Quarter Performance

Posted on December 2, 2021 by MissionIR

Report notes significant and swift advancements in company R&D pipeline and overall business Preliminary data indicates CYB003 may provide significant treatment benefits that address limitations of oral psilocybin CYBN programs and new psychedelic chemical entities have potential to transform treatment … Continue reading →

Posted in Cybin Inc. CYBN, Small Cap News | Leave a comment

Nemaura Medical Inc. (NASDAQ: NMRD) Releases Q2-2021 Results, Signs Global Commercial Contract with MySugarWatch DuoPack Limited

Posted on December 2, 2021 by MissionIR

NMRD releases fiscal Q2-2021 results, provides business update Highlights include pending revenue recognition, global commercial contract with MySugarWatch DuoPack Limited, appointment of Dr. Osama Hamdy to advisory board Company operates at intersection of $59 billion Type 2 diabetes market, $50+ … Continue reading →

Posted in Small Cap News | Leave a comment

MissionIRNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Announces Participation in Future of Healthcare Conference

Posted on December 2, 2021 by MissionIR

Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), will be presenting in the upcoming Stifel GMP second annual Future of Healthcare Conference. The conference, which is slated for Dec. 8, 2021, will include a … Continue reading →

Posted in Cybin Inc. CYBN, MissionIRNewsBreaks | Leave a comment